Saint Luke’s Health System is committed to the health and safety of our patients, visitors, and staff. Effective Nov. 1, 2021, full COVID-19 vaccination is a condition of employment for all SLHS employees.
Saint Luke’s Health System includes 18 hospitals and campuses, home care and hospice, behavioral health care, hundreds of physician practices, a life-plan senior living community, and more facilities across the Kansas City region.
Saint Luke’s Hospital is one of only 75 hospitals in the world to achieve this nursing milestone four times in a row.
At Saint Luke’s, we understand that the health of our organization is directly tied to the health of our team. Your physical, emotional, spiritual, and financial wellness are important to us, which is why we offer a comprehensive and competitive array of benefits and health enhancement programs to care for you and your family. Discover how our benefits can support you.
The city we call home is a thriving and diverse metropolitan hub of activity, home to delicious cuisine, historic arts and music communities, world-class museums, and champion sports teams. Kansas City celebrates its history while continuing to innovate, and the affordable cost of living and family-friendly amenities—from daycare to schools, parks, and zoos—makes our community one of the top U.S. cities in which to live and work.
Dapagliflozin (Farxiga; AstraZeneca) eases symptoms and physical limitations among patients who have heart failure with preserved ejection fraction (HFpEF) within a relatively short time period, the PRESERVED-HF trial shows, adding...Read more >
Treatment with dapagliflozin improves the symptoms of patients with heart failure with preserved ejection fraction (HFpEF), according to new findings presented at the Heart Failure Society of America's Annual Scientific Meeting....Read more >
The SGLT2 inhibitor dapagliflozin scored a clear win in a randomized, controlled trial with more than 300 U.S. patients with heart failure with preserved ejection fraction (HFpEF), showing a significant...Read more >
Symptoms of heart failure with preserved ejection fraction (HFpEF) improved with dapagliflozin (Farxiga) therapy, the PRESERVED-HF trial showed. After 12 weeks of treatment, Kansas City Cardiomyopathy Questionnaire (KCCQ) clinical summary...Read more >
The team at Saint Luke's Mid America Heart Institute performed its 900th heart transplant—a milestone decades in the making. Leawood resident Stephen White - a successful veterinarian, deacon at this church,...Read more >
Laurent Duvernay-Tardif has returned to the Kansas City Chiefs roster a year after making the decision to opt of the 2020 NFL season. Instead of joining his teammates to try...Read more >
Sign up to receive the latest job alerts.